Quick Links

How to Find Us

Division of Rheumatology
1959 NE Pacific St
Health Science Bldg BB561
Campus Box 356428
Seattle, WA 98195

Email Us

Phone: 206-543-3414
 

Click here for directions & other rheumatology locations.
 

Faculty

Keith B. Elkon, M.D.

 

The Mart Mannik, M.D.-Lucile T. Henderson
     Endowed Professor in Rheumatology
Head, Division of Rheumatology
Adjunct Professor of Immunology

 
750 Republican Street
Box 358060
Seattle, WA 98109
Phone: 206-543-3414
Email: elkon@uw.edu

 

 

EDUCATION AND TRAINING

  • M.B., B.Ch. (M.D. equivalent) University of the Witwatersr and Medical School M.R.C.P.
    (Member of the Royal College of Physicians, United Kingdom)
  • Residency, Hammersmith Hospital and Guy's Hospital, London, United Kingdom
  • Fellowship, Weill Medical College, Cornell University, New York

 

CURRENT RESEARCH INTERESTS

 

Dr. Elkon received his medical degree from the University of Witwatersrand, Johannesburg South Africa in 1974 and membership to the Royal College of Physicians (MRCP) in 1978. He received postdoctoral training at the Hammersmith Hospital, London and at the Weill Medical College of Cornell University, New York. Dr. Elkon was formerly Director of the Graduate Program in Immunology and Professor of Medicine at Cornell. He was appointed as Head, Division of Rheumatology, at UW in August, 2001.

 

Dr. Elkon studies how dead and dying cells are processed in the body in lupus. In addition, he is investigating how cells grow and cause inflammation in rheumatoid arthritis and scleroderma. Read more about his research here...

 

 

REPRESENTATIVE PUBLICATIONS

 

  • Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C, De Ravin SS, Smith CK, Malech HL, Ledbetter JAElkon KB, Kaplan MJ.Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease.Nat Med. 2016 Jan 18. doi: 10.1038/nm.4027. [Epub ahead of print] PMID: 26779811

 

  • Colonna L, Parry GC, Panicker S, Elkon KB.Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity. Clin Immunol. 2016 Jan 6;163:84-90. doi: 10.1016/j.clim.2015.12.017. [Epub ahead of print] PMID: 26769276

     

  • Han CY, Tang C, Guevara ME, Wei H, Wietecha T, Shao B, Subramanian S, Omer M, Wang S, O'Brien KD, Marcovina SM, Wight TN, Vaisar T, de Beer MC, de Beer FC, Osborne WR, Elkon KB, Chait A. Serum amyloid A impairs the antiinflammatory properties of HDL. J Clin Invest. 2016 Jan 4;126(1):266-81. doi: 10.1172/JCI83475. Epub 2015 Dec 7. PMID: 26642365

 

  • An J, Woodward JJ, Sasaki T, Minie M, Elkon KB.Cutting Edge: Antimalarial Drugs Inhibit IFN-β Production through Blockade of Cyclic GMP-AMP Synthase-DNA Interaction.J Immunol. 194:4089-93, 2015. PMID: 25821216

     

  • Barrat FJ, Elkon KB, Fitzgerald KA. Importance of Nucleic Acid Recognition in Inflammation and Autoimmunity. Annu Rev Med. 2016 Jan 14;67:323-36. doi: 10.1146/annurev-med-052814-023338. Epub 2015 Nov 2.PMID: 26526766

     

  • Weinstein JR, Quan Y, Hanson JF, Colonna L, Iorga M, Honda S, Shibuya K, Shibuya A, Elkon KB, Möller T. IgM-Dependent Phagocytosis in Microglia Is Mediated by Complement Receptor 3, Not Fcα/μ Receptor. J Immunol. 2015 Dec 1;195(11):5309-17. doi: 10.4049/jimmunol.1401195. Epub 2015 Oct 23. PMID: 26500348

  • Buyon JP, Cohen P, Merrill JT, Gilkeson G, Kaplan M, James J, McCune WJ, Bernatsky S, Elkon K.
    A highlight from the LUPUS 2014 meeting: eight great ideas. Lupus Sci Med. 2015 Jun 30;2(1):e000087. doi: 10.1136/lupus-2015-000087. eCollection 2015. Review. PMID: 26167290

 

  • Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C , De Ravin SS, Smith CK, Malech HL, Ledbetter JA, Elkon KB, Kaplan MJ (co-last authors). Mitochondrial ROS generate NETs enriched in oxidized interferogenic mitochondrial DNA and contribute to lupus-like disease. Nature Medicine, 2015, in revision

 

  • An J, Woodward JJ, Sasaki T, Minie M, Elkon KB. Cutting Edge: Antimalarial Drugs Inhibit IFN-β Production through Blockade of Cyclic GMP-AMP Synthase-DNA Interaction. J Immunol. 194:4089-93, 2015.

 

  • Sisirak V, Ganguly D, Lewis KL, Couillault C, Tanaka L, Bolland S, D’Agati V, Elkon KB, Reizis B. Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus. J Exp Med, 2011:1969-1976, 2014.

 

  • Colonna L, Lood C, Elkon KB. Beyond apoptosis in lupus. Curr Opin Rheumatol. 26:459-466, 2014.

 

  • Wiedeman A, Santer DM, Yan W, Miescher S, Kaisermann F, Elkon KB. Contrasting mechanisms of interferon-α inhibition by intravenous immunoglobulin after stimulation with immune complexes versus toll like receptor agonists. Arthritis Rheum, Jul 9. doi: 10.1002/art.38082. [Epub ahead of print], 2013. Commentary Arthritis Rheum, same issue and Nature Rev Rheum, September, 2013.

 

  • Giltiay NV, Chappell CP, Sun X, Kolhatkar N, Teal T, Wiedeman A, Kim J, Tanaka L, Buechler MB, Hamerman JA, Imanishi-Kari T, Clark EA, Elkon KB. Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells. J Exp Med, 210:2713-23, 2013.

 

  • Sun XZ, Wiedeman A, Agrawal N, Teal TH, Tanaka L, Hudkins KL, Alpers CE, Bolland S, Buechler M, Hamerman JA, Ledbetter JA, Liggitt D, Elkon KB. Increased RNase expression reduces inflammation and prolongs survival in TLR7 transgenic mice. J Immunol, 190:2536-2543, 2013.

 

  • Elkon KB, Wiedeman A. Type I IFN system in the development and manifestations of SLE. Current Opinion Rheumatol, 24:499-505, 2012.

 

  • Peng Y-F, Elkon KB. Autoimmunity in MFG-E8-deficient mice is associated with altered trafficking and enhanced cross-presentation of apoptotic cell antigens. J Clin Invest, 121:2221-2241, 2011.

 

 

 

Quick Links:

Elkon Lab | Division Publications | Clinical Faculty

 

 

Go to top